77 related articles for article (PubMed ID: 18669503)
21. The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study.
Kosmidis ML; Alexopoulos H; Tzioufas AG; Dalakas MC
J Neurol Sci; 2013 Nov; 334(1-2):123-5. PubMed ID: 23998706
[TBL] [Abstract][Full Text] [Related]
22. Formation of amyloid-beta oligomers in brain vascular smooth muscle cells transiently exposed to iron-induced oxidative stress.
Frackowiak J; Potempska A; Mazur-Kolecka B
Acta Neuropathol; 2009 May; 117(5):557-67. PubMed ID: 19221770
[TBL] [Abstract][Full Text] [Related]
23. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.
Lin HC; Hsieh HM; Chen YH; Hu ML
Neurotoxicology; 2009 Jul; 30(4):622-7. PubMed ID: 19635394
[TBL] [Abstract][Full Text] [Related]
24. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 2007 Nov; 19(6):550-9. PubMed ID: 17917534
[TBL] [Abstract][Full Text] [Related]
25. IL-1
Schmidt K; Wienken M; Keller CW; Balcarek P; Münz C; Schmidt J
Mediators Inflamm; 2017; 2017():5470831. PubMed ID: 28167851
[TBL] [Abstract][Full Text] [Related]
26. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
[TBL] [Abstract][Full Text] [Related]
27. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
29. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
30. Increased [11C]PIB-PET levels in inclusion body myositis are indicative of amyloid beta deposition.
Maetzler W; Reimold M; Schittenhelm J; Vorgerd M; Bornemann A; Kötter I; Pfannenberg C; Reischl G; Schöls L
J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1060-2. PubMed ID: 20732867
[No Abstract] [Full Text] [Related]
31. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
[TBL] [Abstract][Full Text] [Related]
32. Amyloid-beta accumulation caused by chloroquine injections precedes ER stress and autophagosome formation in rat skeletal muscle.
Ikezoe K; Furuya H; Arahata H; Nakagawa M; Tateishi T; Fujii N; Kira J
Acta Neuropathol; 2009 May; 117(5):575-82. PubMed ID: 19198858
[TBL] [Abstract][Full Text] [Related]
33. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
34. Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis.
Kosmidis ML; Pikazis D; Vlachoyiannopoulos P; Tzioufas AG; Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e581. PubMed ID: 31355317
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression.
Quiroz-Baez R; Rojas E; Arias C
Neurochem Int; 2009 Dec; 55(7):662-70. PubMed ID: 19560504
[TBL] [Abstract][Full Text] [Related]
36. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
Philipson O; Lannfelt L; Nilsson LN
FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
38. Fourteen newly recognized proteins at the human neuromuscular junctions--and their nonjunctional accumulation in inclusion-body myositis.
Askanas V; Engel WK; Alvarez RB
Ann N Y Acad Sci; 1998 May; 841():28-56. PubMed ID: 9668220
[No Abstract] [Full Text] [Related]
39. Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus.
Hiltunen M; Mäkinen P; Peräniemi S; Sivenius J; van Groen T; Soininen H; Jolkkonen J
Neurobiol Dis; 2009 Jul; 35(1):103-13. PubMed ID: 19426802
[TBL] [Abstract][Full Text] [Related]
40. The intracellular domain of amyloid precursor protein induces neuron-specific apoptosis.
Nakayama K; Ohkawara T; Hiratochi M; Koh CS; Nagase H
Neurosci Lett; 2008 Oct; 444(2):127-31. PubMed ID: 18722509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
